Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin versus albumin for prevention of paracentesis-associated adverse events in cirrhosis with tense ascites
NL-OMON23876Active, not recruiting
- Sponsor
- Foundation for Liver Research
- Start
- Dec 2005
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of terlipressin and albumin (human) in Cirrhosis and ascites, sponsored by Foundation for Liver Research. Started Dec 2005; status: active, not recruiting.
02
Drugs
terlipressinalbumin (human)
03
Conditions
Cirrhosisascites
Beyond the preview
Go deeper on NL-OMON23876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23876.